Marker Therapeutics is trading 6.96% up at $1.23, despite the broader market moving lower on September 14, 2026; the move remains unexplained.
- No credible company-specific announcement, filing, earnings update, or regulatory event was identified for the session.
- The investor-relations page shows no newer September 14 catalyst.
- The latest notable analyst action was an August 21 Buy reiteration.